EUIPO trademark

RIVMEY

Opposition periodEUIPOWord markClass 5

"RIVMEY" is a word mark owned by Amgen Inc., filed at the EUIPO on September 18, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Amgen Inc. portfolioGet this data via the API
Official EUIPO record
RIVMEY
Word mark as filed with the EUIPO
Status
Opposition period
Filed
September 18, 2026
Registered
Not yet
Priority date
March 26, 2026
Claimed from United States
Application no.
019424246
Registration no.
Not yet
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns RIVMEY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Amgen Inc.

AMGN

2,426 trademarks in the portfolioView company

Representative

Chiever BV

Chiever BV

Goods and services

What the mark covers

The products and services RIVMEY is filed for, grouped by Nice class.

  • Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases, blood diseases, bone and skeletal diseases, cancer, cardiovascular diseases, sleep apnea, central nervous system diseases, cluster headaches, coronavirus disease, and Crohn's disease; Pharmaceutical preparations for treating dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammatory diseases and disorders, kidney diseases, liver diseases, lupus, and mental disorders; Pharmaceutical preparations for treating metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative or neurological diseases and disorders, obesity, chronic weight management, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases; Pharmaceutical preparations

FAQ

About RIVMEY

Who owns the trademark "RIVMEY"?

The EUIPO trademark "RIVMEY" (application 019424246) is owned by Amgen Inc.

What is the status of "RIVMEY"?

Its status at the EUIPO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RIVMEY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0b87a-7374-7527-876e-46c49d6e972c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0b87a-7374-7527-876e-46c49d6e972c",
  "object": "trademark",
  "mark_text": "RIVMEY",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "EM",
  "application_number": "019424246",
  "filing_date": "2026-09-18",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Amgen Inc.",
      "entity_id": "ent_019eb6fb-7ab7-71bf-a46d-b0ba9848c4af"
    }
  ]
}